Dr. Marcia Taylor was in attendance at the virtual AD/PD conference taking that took place on March 9-14, 2021. This event specializes in Alzheimer’s and Parkinson’s research and is ordinarily held in Europe each spring.
Dr. Taylor noted that presented work demonstrated impressive advances in the field of plasma biomarkers for diagnosing and following course of treatment in AD. Plasma phospho-tau appeared to be a front-runner not only for early diagnosis but also for measuring the impact of a disease-modifying therapeutics. While the research models used in AD have significant limitations, Dr. Taylor noted it was heartening to hear the broad acknowledgement of these limitations, as these difficulties are driving innovation in AD research.